Viatris Inc.
A global healthcare company that provides a portfolio of medicine and medical solutions for patients and healthcare systems.
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Viatris stock, predicting it could reach a price of $12.2.
Financial Health
Viatris is generating strong revenue and cash flow, indicating solid financial performance and stability.
Dividend
Viatris Inc. offers an above-average dividend yield of 5.53%, making it appealing for income-focused investors. If you invested $1000 you would be paid $48 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring VTRS
Navigating Pharma Price Controls
President Trump's ultimatum to major pharmaceutical firms to lower drug prices creates significant market uncertainty for brand-name drug makers. This situation could benefit companies that thrive on reducing healthcare costs, such as generic drug manufacturers and prescription discount platforms.
Published: August 4, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Global manufacturing reach
Viatris’s wide geographic footprint helps distribution and scale, though regional regulations and pricing can influence returns.
Generics and biosimilars
Exposure to generics and emerging biosimilars offers volume opportunities, but pricing competition and approval timelines are important to watch.
Operational focus
Management has emphasised integration and cash generation to improve resilience, yet execution and market dynamics can affect results.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
